Sep 02, 2019
Last Posted: Aug 29, 2019
- Is BRCA mutational status a predictor of platinum-based chemotherapy related hematologic toxicity in high-grade serous ovarian cancer patients?
Tomao Federica et al. Gynecologic oncology 2019 154(1) 138-143 - New BRCA recommendations: What primary care doctors must know,
by Kevin B. O?Reilly, AMA, August 22, 2019 - Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Nelson Heidi D et al. JAMA 2019 322(7) 666-685 - Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
et al. JAMA 2019 322(7) 652-665 - US Preventive Services Task Force Breast Cancer Recommendation Statement on Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer.
Newman Lisa et al. JAMA surgery 2019 Aug - USPSTF Recommendation Expands Cancer Screening Pool, Concerns Still Remain
KL Kahl, Cure, August 26, 2019 - New USPSTF BRCA Recommendations Still Fall Short,
by Brielle Benyon, Oncology Nursing News, August 24, 2019 - Should I Be Tested for BRCA Mutations?
Jin Jill et al. JAMA 2019 322(7) 702 - Cancer Patient Says Question Could Save Lives: 'Do You Have Eastern European Jewish Ancestry?'
C Goldberg, WBUR, August 21, 2019 - Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer US Preventive Services Task Force Recommendation Statement
USPSTF, JAMA, August 20, 2019
.png)
No hay comentarios:
Publicar un comentario